|
"liou jm"的相關文件
顯示項目 1-10 / 19 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-02-06 |
Multicenter prospective first-line helicobacter pylori eradication for localized gastric “Pure” diffuse large B-cell lymphoma
|
Chen, LT;Yeh, KH;Lin, CW;Wang, TE;Wang, MC;Hsiao, CF;Chen, CC;Liou, JM;Wang, HP;Wei, MF;Lee, HW;Shun, CT;Liu, TW;Tien, HF;Wu, MS;Kuo, SH;Cheng, AL |
| 國家衛生研究院 |
2024-11-18 |
Cooperative participation of CagA and NFATc1 in the pathogenesis of antibiotics-responsive gastric MALT lymphoma
|
Tsai, HJ;Yeh, KH;Lin, CW;Wu, MS;Liou, JM;Hsu, PN;Zeng, YS;Wei, MF;Shun, CT;Wang, HP;Chen, LT;Cheng, AL;Kuo, SH |
| 國家衛生研究院 |
2024-09-19 |
A population-based study of familial coaggregation and shared genetic etiology of psychiatric and gastrointestinal disorders
|
Pan, YJ;Lin, MC;Liou, JM;Fan, CC;Su, MH;Chen, CY;Wu, CS;Chen, PC;Huang, YT;Wang, SH |
| 國家衛生研究院 |
2022-02-16 |
Current status of the spectrum and therapeutics of helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Yeh, KH;Lin, CW;Liou, JM;Wu, MS;Chen, LT;Cheng, AL |
| 中山醫學大學 |
2020 |
Effects of Vigiis 101-LAB on a healthy population's gut microflora, peristalsis, immunity, and anti-oxidative capacity: A randomized, double-blind, placebo-controlled clinical study
|
Chen, CL; Liou, JM; Lu, TM; Lin, YH; Wang, CK; Pan, TM |
| 國家衛生研究院 |
2019-11-14 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai, HJ;Tai, JJ;Chen, LT;Wu, MS;Yeh, KH;Lin, CW;Wang, TE;Wang, HP;Yu, FJ;Liou, JM;Hsiao, CF;Cheng, TY;Yeh, HJ;Ko, CW;Chen, MJ;Lo, GH;Hsu, PI;Chang, CS;Hwang, WS;Chuang, SS;Lee, HW;Shun, CT;Chiu, CF;Wang, WM;Hsieh, CY;Liu, TW;Lin, JT;Kuo, SH;Cheng, AL |
| 國家衛生研究院 |
2018-08-31 |
Systematic review with network meta-analysis: Effectiveness of therapies for second-line helicobacter pylori eradication
|
Yeo, YH;Hsu, CC;Lee, CC;Ho, HJ;Lin, JT;Wu, MS;Liou, JM;Wu, CY;Taiwan Gastrointestinal Disease and Helicobacter Consortium |
| 國家衛生研究院 |
2018-01 |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis
|
Yeo, YH;Shiu, SI;Ho, HJ;Zou, B;Lin, JT;Wu, MS;Liou, JM;Wu, CY;Consortium, Taiwan Gastrointestinal Disease and Helicobacter |
| 國家衛生研究院 |
2017-10 |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Yeh, KH;Wu, MS;Lin, CW;Wei, MF;Liou, JM;Wang, HP;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2017-01 |
Expressions of the CagA protein and CagA-signaling molecules predict H. pylori-dependence of early-stage gastric DLBCL
|
Kuo, SH;Chen, LT;Lin, CW;Yeh, KH;Shun, CT;Tzeng, YS;Liou, JM;Wu, MS;Hsu, PN;Cheng, AL |
顯示項目 1-10 / 19 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
